Attention-deficit/hyperactivity disorder symptom heterogeneity in neurofibromatosis type 1: Beyond symptom burden
Developmental Medicine & Child Neurology, Vol.First online, pp.1-2
03/09/2026
2
Attention-deficit/hyperactivity disorder (ADHD) symptoms are among the most clinically significant neurodevelopmental features associated with neurofibromatosis type 1 (NF1), contributing to cognitive, academic, and psychosocial difficulties in childhood. A recent systematic review demonstrated that children with NF1 experience significantly greater ADHD symptom burden than unaffected peers, with inattentive symptoms particularly prominent.1 However, important questions remain regarding the heterogeneity of ADHD symptom presentation, including differences in symptom severity between age groups, the existence of distinct symptom profiles, and whether these profiles differ in their developmental course and clinical significance. Understanding this heterogeneity is essential for improving clinical management and guiding future research.
This commentary is on the original article by Hou et al. To view this paper visit <a href>https://doi.org/10.1111/dmcn.70423</a href>
- Attention-deficit/hyperactivity disorder symptom heterogeneity in neurofibromatosis type 1: Beyond symptom burden
- Belinda Barton - Southern Cross University
- Developmental Medicine & Child Neurology, Vol.First online, pp.1-2
- Wiley
- 2
- Open access publishing facilitated by Southern Cross University, as part of the Wiley - Southern Cross University agreement via the Council of Australasian University Librarians.
- 991013395345402368
- © 2026 The Author(s).
- Psychology and Social Health; Faculty of Health
- English
- Editorial